Form 4: Myriad Genetics Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Dale Muzzey, Chief Scientific Officer of Myriad Genetics, disposed of shares to cover tax obligations related to vesting restricted stock units.
Summary
- On April 14, 2024, Dale Muzzey, the Chief Scientific Officer of Myriad Genetics Inc., disposed of 940 shares of common stock.
- The transaction was executed to cover tax withholding obligations related to the vesting of restricted stock units.
- The shares were sold at a price of $19.55 per share.
- Following the transaction, Muzzey directly owns 110,113 shares of Myriad Genetics Inc.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a routine transaction for tax purposes and doesn't necessarily reflect a change in the executive's confidence in the company.
Industry Context
Form 4 filings are a routine part of the US stock market, providing transparency into the transactions of company insiders. This filing indicates a standard transaction to cover tax obligations, which is a common practice.
Key Dates
| Date | Description |
|---|---|
| 04/12/2024 | Date used to determine the closing price of Myriad common stock for calculating the number of shares withheld. |
| 04/14/2024 | Date of the transaction where shares were disposed of to cover tax obligations. |
| 04/15/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.